News & Events

Press Releases

Press Releases

Date Title
2020-09-11 TLC to Present at Cantor Virtual Global Healthcare Conference
2020-09-09 TLC to Present at HC Wainwright & Co. 22nd Annual Global Investment Conference
2020-09-03 TLC to Present at Baird’s 2020 Global Healthcare Conference
2020-08-26 TLC and 3SBio Announce Acceptance of Marketing Authorization Application for Ampholipad™ in China
2020-08-14 TLC Submits Investigational New Drug (IND) Application for TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
2020-08-05 TLC Reports Second Quarter 2020 Financial Results and Provides Business Update
2020-07-15 Manuscript Describes How TLC’s Inhalable Liposomal Hydroxychloroquine May Provide Clinical Benefit and Serve as Potential Treatment for COVID-19
2020-06-30 TLC Announces Completion of US$23 Million Financing
2020-06-21 TLC Announces Scale-up Production Approval for Ampholipad™
2020-05-31 TLC Announces Topline Results for TLC590 Phase II Trial for Postsurgical Pain Management following Bunionectomy
2020-05-18 TLC Highlights Findings in Abstract Accepted at Osteoarthritis Research Society International (OARSI) 2020 and Published in Osteoarthritis and Cartilage
2020-05-13 TLC Reports First Quarter 2020 Financial Results and Provides Business Update
2020-05-04 TLC Earns Highest Ranking in Corporate Governance Evaluation Six Years in a Row
2020-02-12 TLC Announces Early Completion of Patient Enrollment in TLC590 Phase II Clinical Trial following Bunionectomy
2020-02-11 TLC Reports Fiscal Year End 2019 Financial Results and Provides Business Update
2020-01-08 TLC Announces Dosing of First Patients in Part 2 of TLC590 Phase II Trial for Postsurgical Pain following Bunionectomy
2020-01-02 TLC to Present at 38th Annual JP Morgan Healthcare Conference